75N95022F00002↗

Name: 75N95022F00002: Integrated Care and Treatment for Severe Infectious Diseases and Substance Use Disorders (Sud) Among Hospitalized Patients (Ctn-0121). 09/28/2022 - 02/07/2026. DSC6. 75N95022F00002 (To2).
Creator: SpendQuery

INTEGRATED CARE AND TREATMENT FOR SEVERE INFECTIOUS DISEASES AND SUBSTANCE USE DISORDERS (SUD) AMONG HOSPITALIZED PATIENTS (CTN-0121). 09/28/2022 - 02/07/2026. DSC6. 75N95022F00002 (TO2).

Delivery Order · National Institutes of Health · to The Emmes Company, LLC (UEI NBQCBJ6FXBU4) · data as of 2026-09-30

Obligated to date$667.7K2 actions

Current value$2.07Mwith options exercised

Period2022-09-28 → 2027-09-30current end date

Up for re-bid: ends 2027-09-30. Recompete brief → · CTN Data, Statistics, and Clinical Trial Support Center (DSC7) ↗

What it is

Product or service: Health R&D Services; Health Care Services; Basic Research (PSC AN11)
Industry: Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) (NAICS 541715)
Contracting office: National Institutes of Health Nida (75N950)
Competition: Full and open competition
Pricing: Cost plus fixed fee
How it was bought: Single-award IDIQ · under 75N95022D00017
Solicitation: 75N95022F00002
Where the work is: Montgomery, MD · district MD-08
Topics: opioids

Obligations by fiscal year

FY2025$667.7K

FY2026$0

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

2 actions since 2025-07-29. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2026-01-27	P00002	Supplemental agreement (work within scope)	$0	INTEGRATED CARE AND TREATMENT FOR SEVERE INFECTIOUS DISEASES AND SUBSTANCE USE DISORDERS (SUD) AMONG HOSPITALIZED PATIENTS (CTN-0121). 09/28/2022 - 09/30/2027. DSC6. 75N95022F00002 (TO2).
2025-07-29	P00001	Option exercised	$667.7K	INTEGRATED CARE AND TREATMENT FOR SEVERE INFECTIOUS DISEASES AND SUBSTANCE USE DISORDERS (SUD) AMONG HOSPITALIZED PATIENTS (CTN-0121). 09/28/2022 - 02/07/2026. DSC6. 75N95022F00002 (TO2).

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗